Ryzneuta J Code: J9361
Injection, efbemalenograstim alfa-vuxw, 0.5 mg
Drug & Product Overview
About Ryzneuta
Ryzneuta is a medication aligned to the HCPCS J Code: J9361 for billing, pricing, and reimbursement purposes in the United States. It is an Oncologic Supportive Care drug administered via the subcutaneous route and manufactured by Acrotech Biopharma.
Manufacturers, reach out to us to add more information.
NDC Code Information
Based on publicly available CMS files. The list of NDCs below is not exhaustive.
| NDC Code | Package | Manufacturer | HCPCS Units | WAC | AWP |
|---|---|---|---|---|---|
| 72893-0016-02 | 20 MG / 1 MLRyzneuta Subcutaneous Injection 20 MG/1ML - 1 SYRINGE in 1 CARTON (72893-016-02) / 1 mL in 1 SYRINGE | Acrotech Biopharma Inc | 40 | $4,600.00 $115.00 / unit | $5,520.00 $138.00 / unit |
Effective 5/7/25 (WAC & AWP)
Ryzneuta Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →Historical Graphing and Billing Calculator
Estimates only. Payer reimbursement varies by contract, site of care, and sequestration.
Ryzneuta CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96372 | Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular |
This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →
Ryzneuta Medically Unlikely Edits (MUE)
The most billing units of J9361 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.5 mg.
MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →
Ryzneuta Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available Ryzneuta billing and coding guide?
Are there any available Ryzneuta patient assistance programs?
Where can I find Ryzneuta prescribing information?
Where can I find Ryzneuta side effect information?
Does billing Ryzneuta require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.